Table 1.

Comparison of baseline characteristics between non-recurrent and recurrent HCC patients after liver transplantation.

	Non-recurrence (N = 281)	Recurrence (N = 50)	p value
Gender (n)			0.095
Male	225	45
Female	56	5
Age (years)	55.38 ± 0.475	52.14 ± 1.146	0.006*
HBsAg (n)			0.01*
Negative	61	3
Positive	220	47
AFP (ng/ml)	477.88 ± 164.67	4882.72 ± 2509.78	0.000*
No. of tumors (n)a	1.94 ± 0.10	3.34 ± 0.43	0.002*
The largest size of tumor (cm)a	3.02 ± 0.08	4.15 ± 0.43	0.003*
Macrovascular invasion (n)a			0.000*
No	264	39
Yes	7	9
TNM staging (n)a			0.000*
I	109	9
II	144	25
III	14	13
Milan criteria (n)a			0.000*
Within criteria	192	20
Beyond criteria	81	29
UCSF criteria (n)a			0.000*
Within criteria	222	21
Beyond criteria	51	28
Vascular permeation (n)a			0.000*
No	190	18
Yes	71	29
Tumor differentiation (n)a			0.025*
Well-differentiated	78	5
Moderately differentiated	156	33
Poorly differentiated	12	5
Undifferentiated	2	0
Graft weight to recipient ESLV (%) (n)a			0.018*
<60%	145	35
≥60%	134	15

ESLV estimated standard liver volume.

*p < 0.05.

^aTotal number less than 331 due to missing data.